Management of Elevated Triglycerides
Lifestyle interventions are the first line of therapy for all patients with persistent hypertriglyceridemia, with specific recommendations based on triglyceride levels. 1
Classification of Hypertriglyceridemia
- Normal: <150 mg/dL 2
- Mild: 150-199 mg/dL 2
- Moderate: 200-499 mg/dL 2
- Severe: 500-999 mg/dL 2
- Very severe: ≥1000 mg/dL 2
Initial Assessment
- Evaluate for secondary causes: excessive alcohol intake, uncontrolled diabetes, hypothyroidism, renal disease, liver disease, and certain medications 2
- Assess cardiovascular risk factors and determine risk of pancreatitis, particularly with triglycerides ≥500 mg/dL 2
- Review medications that may contribute to hypertriglyceridemia (estrogen therapy, thiazide diuretics, beta-blockers) 3
Lifestyle Interventions
Weight Loss
- Target 5-10% reduction in body weight, which can decrease triglycerides by up to 20% 1, 2
- A dose-response relationship exists between weight loss and triglyceride reduction, with some patients experiencing up to 70% reduction 1
Dietary Modifications
For mild to moderate hypertriglyceridemia (150-499 mg/dL):
For severe hypertriglyceridemia (500-999 mg/dL):
For very severe hypertriglyceridemia (≥1000 mg/dL):
Physical Activity
- Engage in at least 150 minutes per week of moderate-intensity or 75 minutes per week of vigorous aerobic activity 1, 2
- Regular endurance exercise training is most effective when baseline triglycerides are elevated (≥150 mg/dL) 1
Alcohol
- For triglycerides 500-999 mg/dL: restrict alcohol 1
- For triglycerides ≥1000 mg/dL: complete abstinence 1
Pharmacologic Therapy
For Severe Hypertriglyceridemia (≥500 mg/dL)
Fibrates are first-line drug therapy to reduce the risk of pancreatitis 2, 3
Prescription omega-3 fatty acids are indicated as adjunct to diet 1
For Moderate Hypertriglyceridemia (200-499 mg/dL)
- Consider statins if there is elevated LDL-C or increased cardiovascular risk 2
- If triglycerides remain elevated after 3 months of optimized lifestyle modifications, consider adding prescription omega-3 fatty acids or fenofibrate 2
Special Considerations
- Optimize glycemic control in patients with diabetes, as it can significantly improve triglyceride levels 1, 2
- In patients with markedly elevated triglycerides and insulin insufficiency, treat hyperglycemia first, then re-evaluate hypertriglyceridemia 1
- For patients with severe renal impairment, avoid fenofibrate or use with caution at reduced doses 3
- Monitor for increased risk of atrial fibrillation with prescription omega-3 fatty acids 2
Follow-up
- Monitor lipid levels periodically, typically at 6-12 weeks after implementing interventions 2, 3
- Consider reducing medication dosage if lipid levels fall significantly below target range 3
- Withdraw therapy if there is inadequate response after two months of treatment with maximum recommended dose 3
Common Pitfalls
- Failing to address secondary causes before initiating pharmacologic therapy 3
- Using lower-fat, higher-carbohydrate diets, which may lessen triglyceride reduction compared to higher-fat, lower-carbohydrate weight loss diets 1
- Not individualizing dietary fat content based on triglyceride levels 1
- Overlooking the importance of registered dietitian nutritionists in providing individualized Medical Nutrition Therapy for optimal lipid lowering 1